Skip to main navigation Skip to search Skip to main content

A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia

  • Elias Jabbour
  • , Nicholas J. Short
  • , Farhad Ravandi
  • , Xuelin Huang
  • , Lianchun Xiao
  • , Guillermo Garcia-Manero
  • , William Plunkett
  • , Varsha Gandhi
  • , Koji Sasaki
  • , Naveen Pemmaraju
  • , Naval G. Daver
  • , Gautam Borthakur
  • , Nitin Jain
  • , Marina Konopleva
  • , Zeev Estrov
  • , Tapan M. Kadia
  • , William G. Wierda
  • , Courtney D. DiNardo
  • , Mark Brandt
  • , Susan M. O'Brien
    • Jorge E. Cortes, Hagop Kantarjian

Research output: Contribution to journal › Article › peer-review

48   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science